Health

AI Drug Firm Raises Funding

Updated 2026-10-23 13:05 UTC 1 source Positive

AI drug firm Pathos secures a significant funding round, valuing the company at $3 billion. The deal combines Tempus data with AI analysis and BMS’s drug development expertise.

Coverage timeline — 1 article

STAT News

STAT+: AI drug firm Pathos raises $237 million, pushing valuation to $3 billion

AI drug firm Pathos raises $237 million, a deal that brings together a big Tempus dataset, AI analysis from Pathos, and drug development from BMS.

2026-10-23 13:00 UTC